T. Murray

Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.

P. Vasey, Stan B. Kaye, Rachel Morrison et al. · PubMed · 1999 · 691 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

The neurotoxic effects of methamphetamine on 5-hydroxytryptamine and dopamine in brain: Evidence for the protective effect of chlormethiazole

A. Richard Green, R DESOUZA, John A. Williams et al. · Neuropharmacology · 1992 · 77 citations

Medicine, Neuroscience, Pharmacology +14

The use of angiotensin II as a potential method of targeting cytotoxic microspheres in patients with intrahepatic tumour

JA Goldberg, T. Murray, DJ Kerr et al. · British Journal of Cancer · 1991 · 40 citations · Full text

Medicine, Oncology, Pharmacology +8

Poor results with technetium-99m (V) DMS and iodine-131 MIBG in the imaging of medullary thyroid carcinoma.

Hilditch Te, Connell Jm, Elliot At et al. · PubMed · 1986 · 34 citations

Medicine, Nuclear Medicine, Radiology +17

Chronic theophylline exposure increases agonist and antagonist binding to A1 adenosine receptors in rat brain

Rebecca Sanders, T. Murray · Neuropharmacology · 1988 · 21 citations

Medicine, Neuroscience, Pharmacology +9